Biovail Corp. International, Chiesi Group deal

BVF’s Crystaal Corp. subsidiary received an exclusive license to market in Canada Chiesi’s Brexidol piroxicam, a non-steroidal anti-inflammatory agent to relieve mild to severe acute pain. Brexidol h...